Nucletron Central Europe Users Meeting



Similar documents
Nucletron Central Europe Users Meeting

Transition from 2D to 3D Brachytherapy in Cervical Cancers: The Vienna Experience. Richard Pötter MD. BrachyNext, Miami, 2014.

Accreditation a tool to help reduce medical errors. Professor Arthur T Porter PC MD FACR FRCPC FACRO

Oncentra Brachy Comprehensive treatment planning for brachytherapy. Time to focus on what counts

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology

Radiotherapy in Hungary: present status and future needs. Tibor Major, PhD National Institute of Oncology Radiotherapy Department Budapest, Hungary

Radiation therapy involves using many terms you may have never heard before. Below is a list of words you could hear during your treatment.

Hands-on course Intensity-Modulated Radiation Therapy Treatment Planning

Non-coronary Brachytherapy

Radiation Therapy for Prostate Cancer: Treatment options and future directions

Second European Blue Sky Conference

Radiation Therapy in Prostate Cancer Current Status and New Advances

Patient Guide. Brachytherapy: The precise answer for tackling breast cancer. Because life is for living

9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium

Radiation Therapy in Prostate Cancer Current Status and New Advances

Program. AUGUST 26 (Wednesday)

Implementation Date: April 2015 Clinical Operations

Radiation Oncologists and Cancer Treatment Facilities Quick Reference Guide

Advances in Surgical Oncology

Szent István Egyetem Gödöll, Páter Károly u. 1., Tudástranszfer Központ (GPS: , ) Szent István University

Accelerated Partial Breast Irradiation (APBI) for Breast Cancer [Pre-authorization Required]

Brachytherapy in Greater Poland Cancer Centre and in Poznan the past and the presence

There must be an appropriate administrative structure for each residency program.

Accelerated Partial Breast Irradiation (APBI) for Breast Cancer [Preauthorization Required]

NOVEL USES OF A CT-ON-RAILS IN AN INTEGRATED BRACHYTHERAPY OR SUITE

MVP/Care Core National 2015 Radiation Therapy Prior Authorization List (Effective January 1, 2015)

The Canadian National System for Incident Reporting in Radiation Treatment (NSIR-RT) Taxonomy March 2, 2015 V2

Brachytherapy of the Uterine Corpus: Some Physical Considerations. Bruce Thomadsen. University of Wisconsin -Madison

Dear Colleagues, We are very much looking forward to meeting you this autumn.

Second European Blue Sky Conference

Cancer research in the Midland Region the prostate and bowel cancer projects

Breast Cancer Accelerated Partial Breast Irradiation Bruce G. Haffty, MD Professor and Chairman Dept Radiation Oncology UMDNJ-RWJMS Cancer Institute

How To Know If You Should Get A Brachytherapy Or Radioactive Seed Implantation

Basic Principles of Documentation, Billing, Coding & Compliance in Radiation Oncology

15-17th October. conference program. CONFESSIONALITY AND UNIVERSITY IN THE MODERN WORLD 20th Anniversary of Károli University

Dear Colleagues and Friends,

Preliminary program 10 OCTOBER, 2014 FRIDAY. 9:10 9:30 Opening ceremony

November 21 22, 2008 Siófok, Hotel Residence Hungary. Seminar on Geriatric Fractures

NIA RADIATION ONCOLOGY CODING STANDARD. Dosimetry Planning

9th NATIONAL AND 4th INTERNATIONAL CONFERENCE OF LOGISTICS DIRECTORS

GYNECOLOGIC CANCERS Facts to Help Patients Make an Informed Decision

Clinical Trials and Radiation Treatment. Gerard Morton Odette Cancer Centre Sunnybrook Research Institute University of Toronto

Prostate Cancer Treatment

Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate

ENERGY ARBITRATION COURT ROLL OF ARBITRATORS

Horizon Blue Cross Blue Shield of New Jersey 2012 Radiation Therapy Payment Rules

Re irradiation Using HDR Interstitial Brachytherapy for Locally Recurrent. Disclosure

Prostate Cancer. What is prostate cancer?

Corporate Medical Policy Brachytherapy Treatment of Breast Cancer

NEW YORK STATE DEPARTMENT OF HEALTH BUREAU OF ENVIRONMENTAL RADIATION PROTECTION EXTERNAL BEAM & BRACHYTHERAPY QUALITY ASSURANCE PROGRAM AUDIT FORM

Radiation Therapy Coverage, Coding, and Reimbursement for New Technologies

Albany Medical Center Chief Medical Physicist Radiation Oncology Imaging and Related Services

1. Provide clinical training in radiation oncology physics within a structured clinical environment.

Special Guest of the Congress. Changes in economic environment as an opportunity to improve competitiveness of listed companies

PROTON THERAPY. Proton Therapy World Market Report Edition 2015 WORLD MARKET REPORT EDITION MEDraysintell

Localised Cancer Treatment. PCI Biotech. Amphinex a new product for localised cancer treatment

Understanding brachytherapy

The Science behind Proton Beam Therapy

MICROPOL Hungarian Seminar and Study Visit AGENDA

Autoradiograph of Ra-223

Protons vs. CyberKnife. Protons vs. CyberKnife. Page 1 UC SF. What are. Alexander R. Gottschalk, M.D., Ph.D.

Radiation Oncology Nursing Care. Helen Lusby Radiation Oncology Nurse BAROC 2012

Call for proposals to host. the. ECSITE ANNUAL CONFERENCE 2018 or ECSITE ANNUAL CONFERENCE 2019

Our Facility. Advanced clinical center with the newest and highly exact technology for treatment of patients with cancer pencil beam

With the project we hope to bring enhanced treatment for better care of our patients who will no

Proton Therapy: Cutting Edge Treatment for Cancerous Tumors. By: Cherilyn G. Murer, JD, CRA

F I K U S Z C O N F E R E N C E

Prostate Cancer Treatment: What s Best for You?

at a critical moment Physician Suggestion Line...

New Horizons. The Future of the Eastern Partnership

National Institute of Oncology - Budapest, Hungary

8 th Central European Orthopaedic Congress

Executive summary. What is proton radiotherapy?

KÁROLY RÓBERT COLLEGE GYÖNGYÖS. Challenges and Prospects for Innovation between

ANNOUNCEMENT OF COMPETITION

Szegedi Tudományegyetem

BIG PUBLIC INVESTMENTS IN THE CITIES OF AGGLOMERATIONS

Proton Therapy Center Czech

The validation of a tumour control probability (TCP) model for supporting radiotherapy treatment planning.

IAEA Human Health Programme

Programme Schedule YRS 2015

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

Dosimetry on the Intraoperative Procedure

(JVC-12/EVC-10/AMDVG-7)

What is a clinical trial? An introduction for patients and families

Transcription:

With delight we present you the preliminary agenda for the Nucletron Central Europe Users Meeting, which will be held on 15-17 October 2009 in Budapest, Hungary. We have aimed for an inspiring programme that looks at brachytherapy from both a scientific and a practical perspective. A Toolkit for Good Medical Practice in Brachytherapy is therefore the theme for this meeting. A host of nationally and internationally renowned experts will address all significant aspects in a series of interactive talks, discussions and video demonstrations. In addition to sharing experiences and giving feedback on new Nucletron technology, we want to focus on how to successfully implement clinical protocols and procedures that drive good-quality results within the technological and socioeconomic context of Central Europe. Brachytherapy has always been the mainstay for treating gynaecological cancers and in fact the standard of care in Central Europe. Going forward, brachytherapy will play an even more crucial role, not only because of the rising incidence of indications like prostate and breast cancer but primarily because of its proven efficacy and efficiency in treating these diseases. At the same time, clinical and technological developments are driving the transition from 2-D (implant-based) to 3-D (volumebased) treatment planning and reinforcing the use of image-guidance for (interstitial) applications. These important developments offer vital inspiration for exploring and discussing sensible solutions that are relevant for your practice. That is why this year s Central Europe Users Meeting will focus on the opportunity to expand from GYN to other body sites and the benefit from key advancements in image-guided and adaptive brachytherapy by using knowledge and technology that is currently available to you. This meeting intends to offer you a toolkit for expanding the extraordinary potential of brachytherapy by breaking the barriers through clinical proof, cost-effectiveness and education. Scientific Committee MD PhD (Budapest) PhD (Budapest) Members MD PhD (Budapest) Jenő Bolgár MD (Kecskemét, HU) Janaki Hadijev MD PhD (Kaposvár, HU) János Fodor MD PhD DSc (Budapest) Erika Groska MSc (Gyula, HU) László Mangel MD PhD (Pécs, HU) József Lövey MD PhD (Budapest) Jenő Pálvölgyi PhD (Győr, HU) Béla Pikó MD (Gyula, HU) Kofi Agyemang Prempeh MD (Győr, HU) Kornélia Szluha MD PhD (Debrecen, HU) László Takácsi-Nagy MD PhD (Budapest) Zoltán Takácsi-Nagy MD PhD (Budapest) Prof László Thurzó MD PhD (Szeged, HU) International Invited Speakers Prof Dimos Baltas PhD DSc (Offenbach, DE) Catharina Beskow MD PhD (Stockholm, SE) Brygida Białas MD PhD (Gliwice, PL) MD (Royal Oak, MI USA) MD (Örebro, SE) Prof Christian Kirisits PhD DSc (Vienna, AT) Gabor Kacso MD (Cluj-Napoca, RO) Anna Kulik MD PhD (Warsaw, PL) Jarosław Łyczek MD PhD (Warsaw, PL) Prof Bogusław Maciejewski MD PhD DSc (Gliwice, PL) Prof Julian Malicki PhD DSc (Poznań, PL) Maryla Kawczyńska PhD (Warsaw, PL) Primož Petrič MD (Ljubljana, SLO) Prof Pavel Slampa MD PhD (Brno, CZ) Prof Andrzej Roszak MD PhD DSc (Poznań, PL) Prof Janusz Skowronek MD PhD DSc (Poznań, PL) Prof Renata Soumarová MD PhD (Novy Jicín, CZ) Grzegorz Zwierzchowski MD PhD (Poznań, PL) Nucletron Speakers Marjorie Imhoff PhD Eric Sewsingh BSc Lisette van der Vight BSc Mehmet Üzümcü PhD Organisers National Institute of Oncology Budapest MD PhD PhD MD Nucletron Netherlands Antar El-Mecky MA Jeske van der Sluijs Hans Galesloot MBA 1

Thursday, 15 October 2009 12:00 14:30 Registration 13:30 14:30 Lunch OPENING CEREMONY 14:30 14:45 Welcome Speeches Jos Lamers CEO Nucletron Head of Radiotherapy NIO, Budapest 14:45 15:00 Speeches by Honorary Patrons Prof Dr Miklós Kásler Director NIO, Budapest László Mangel, President of the Hungarian Society for Radiation Oncology ORAL SESSION I BREAST BRACHYTHERAPY MULTICATHETER APBI Chairpersons Anna Kulik and János Fodor 15:00 15:20 Current Status and Future Perspectives of Multicatheter Breast Brachytherapy 15:20 15:35 15:35 15:50 15:50 16:00 Discussion LDR and HDR Multicatheter APBI 12-Year Result of William Beaumont Hospitals, Royal Oak, MI, USA HDR Multicatheter Brachytherapy for APBI Technique and Long-Term Results of Örebro University Hospital 16:00 16:30 Coffee Break VIDEO PRESENTATION I 16:30 16:50 Breast Implantation Using Nucletron Comfort Catheters and Oncentra Brachy Treatment Planning System 16:50 17:10 New Technology for Breast Brachytherapy 17:10 17:30 Discussion ROUND-TABLE DISCUSSION I 17:30 18:15 BREAST BRACHYTHERAPY Jarosław Łyczek Should We Keep our Good Old Breast Implant Techniques and 2-D Planning or Should We Go for CT-Based Conformal Brachytherapy Planning? Anna Kulik János Fodor Marjorie Imhoff Eric Sewsingh Anna Kulik János Fodor Christian Kirisits Pavel Slampa ORAL SESSION II PROFERRED PAPERS ON BREAST BRACHYTHERAPY Bengt Johansson and Pavel Slampa 3-D CT-Based HDR Interstitial BT for Localised Breast Cancer Plan Evaluation: M.S. Patel Cancer Centre Ganesan Senthil 18:15 18:40 Experience IPSA vs. Geometry-Based Optimisation in Dose Distribution Calculation in Accelerated Partial Breast Irradiation Marta Szlag 19:00 23:00 Dinner and Evening Programme 2

Friday, 16 October 2009 ORAL SESSION III IS THERE ARE A ROLE FOR PREOPERATIVE BRACHYTHERAPY IN TREATING GYN TUMOURS? Chairpersons Catharina Beskow and László Thurzó 08:30 08:45 Pathologic Complete Remission after Preoperative Intracavitary Radiotherapy of Cervical Cancer: Catharina Beskow The Radiumhemmet Experience 08:45 09:00 Tolerance and Efficacy of Preoperative Intracavitary HDR Brachytherapy in IB and IIA Cervical Cancer Brygida Białas 09:00 09:15 Preoperative HDR Brachytherapy in the Treatment of Operable Cervical Carcinoma Status of the Hungarian Júlia Vízkeleti Multicentric Randomised Clinical Trial 09:15 09:45 New Technology for Image-guided Adaptive Brachytherapy for Gynaecological Tumours Lisette van der Vight 09:45 10:00 Discussion Catharina Beskow László Thurzó 10:00 10:30 Coffee Break ROUND-TABLE DISCUSSION II GYNAECOLOGICAL BRACHYTHERAPY Primož Petrič Brygida Białas Christian Kirisits 10:30 11:15 Performing Successful Intracavitary Gynaecological Jarosław Łyczek Brachytherapy without Access to an MRI Facility Andrej Roszak László Thurzó ORAL SESSION IV PROFFERED PAPERS GYNAECOLOGICAL BRACHYTHERAPY László Mangel and Andrzej Roszak Analysis of Standard Loading Patterns for Cervix BT Using MRI-Based Dosimetry Anna Lettmayer Use of Adjustable Applicator System for MRI-Guided BT in Cervical Cancer Árpád Kovács 11:15 12:00 Evaluation of HDR BT Fraction Dose on Local Control and Complication in Patients with Cervical Cancer IB and IIA Małgorzata Kraszkiewicz 12:00 13:00 Lunch ORAL SESSION V Impact of Treatment Time Prolongation on Pelvic Control for Uterine Cervix Cancer Radiobiological Modelling TCP vs. Clinical Outcomes from EBM Pavol Matula NEW DEVELOPEMENTS IN BT PHYSICS INVERSE PLANNING Dimos Baltas and Tibor Major 13:00 13:20 The Role of Inverse Planning in Prostate Brachytherapy Dimos Baltas 13:20 13:35 Optimisation of Image-Based Treatment Plans for Breast HDR Implants 13:35 13:50 Inverse Planning in Gynaecological Brachytherapy Christian Kirisits 13:50 14:05 14:05 14:15 Discussion Recent and Future Developments for Brachytherapy Treatment Planning Eric Sewsingh Mehmet Üzümcu Dimos Baltas 3

ORAL SESSION VII PROFFERED PAPERS BRACHYTHERAPY PHYSICS Maryla Kawczyńska and Christian Kirisits Irregular vs. Regular Seed Loading Pattern in Permanent Prostate Brachytherapy Planning Georgina Fröhlich 14:15 14:45 MRI Modelling of Rectal Dosimeter Probe during MRI-Guided HDR BT for prostate: feasibility and Gergely Antal Initial experiences 14:45 15:15 Coffee Break ROUND-TABLE DISCUSSION III Development of Surface Applicator ( Results) RAISING THE PROFILE OF BRACHYTHERAPY Bogusław Maciejewski Jenő Pálvölgyi 15:15 15:30 Clinical and Economic Sunrise for Brachytherapy Bogusław Maciejewski 15:30 17:15 ORAL SESSION VIII 17:15 18:15 POSTER WALK Moderators DISCUSSION Clinical and Economic Cost-Benefit Ratio of Brachytherapy vs. Other Modalities (e.g. IMRT, Protons) Driving the Cause of Brachytherapy through better Evidence Standardisation and reproducibility (e.g. protocols) Economics (e.g. reimbursement, business plans) Technology Education Lobbying (e.g. health care authorities, health care funds, professional medical associations beyond RT, patients) Dimos Baltas Catharina Beskow Brygida Białas Gabor Kacso Christian Kirisits József Lövey Jarosław Łyczek Bogusław Maciejewski Julian Malicki Primož Petrič Pavel Slampa PROFFERED PAPERS MISCELLANEOUS BRACHYTHERAPY (OTHER THAN BREAST, GYN AND PROSTATE) Janaki Hadijev and Zoltán Takácsi-Nagy Brachytherapy Infrastructure in Poland (2002-2008) HDR BT Endobronchial in Managing Advanced Lung Cancer Comparison of Different Protocols Palliative PDR BT in Treating Recurrent Larynx Cancer HDR BT of Skin Cancer in Material of GPCC Effectiveness of Yttrium-90 Colloid BT in Cystic Craniopharyngeomas József Lövey and Kornélia Szluha 18:15 18:45 Abstracts 1, 2, 4, 7, 8, 10,14, 15, 17, 19, 20, 25, 28, 32 18:30 19:15 Break SOCIAL EVENT AN EVENING OUT IN BUDAPEST Gala Dinner 19:15 23:00 Best Abstracts Awards Party Time Wojciech Bulski Marek Kanikowski Kolumbán Zsuzsa 4

Saturday, 17 October 2009 ORAL SESSION IX DEBATE ON BRACHYTHERAPY FOR LOW-RISK PROSTATE CANCER HDR VS. LDR SEEDS MONOTHERAPY Bengt Johansson and Janusz Skowronek 09:00 09:15 Seeds Brachytherapy as Treatment of Choice 09:15 09:30 HDR Brachytherapy as Treatment of Choice 09:30 09:45 Discussion 09:45 10:00 Proposal for a Central European Multicentric Randomised Clinical Trial Comparing HDR to LDR Seeds Monotherapy 10:00 10:15 VIDEO PRESENTATION II Technique and Treatment Planning of Prostate Seeds Implantation Using the Nucletron FIRST System 10:15 10:30 VIDEO PRESENTATION III Technique and Treatment Planning of HDR Prostate Using Nucletron Oncentra Prostate 10:30 11:00 New Technology for Image-Guided Adaptive Brachytherapy for Prostate Tumours Lisette van der Vight 11:00 11:20 Discussion Lisette van der Vight 11:20 11:45 Coffee break ROUND-TABLE DISCUSSION VI PRACTICE OF PROSTATE HDR AND SEEDS BRACHYTHERAPY Janusz Skowronek 11:45 12:00 Optimisation Traps of HDR to LDR Prostate Brachytherapy Greater-Poland Cancer Centre Experience Dimos Baltas 11:45 12:30 DISCUSSION Learning-curve of HDR and LDR Prostate Brachytherapy Renata Soumarová Grzegorz Zwierzchowski 5

ORAL SESSION X PROFFERED PAPERS PROSTATE BRACHYTHERAPY Jarosław Łyczek and Péter Ágoston Influence of Number of Needles on Prostate HDR Treatment Plan Quality Adam Chichel Salvage BT for Local Recurrences of Prostate Cancer Marzena Gawkowska- 12:30 13:15 Treated Earlier with RT Suwińska Prostate HDR BT 2 years of Treatment at Greater-Poland Cancer Center Marek Kanikowski Closure 13:15 13:30 Closing remarks Open MRI-Guided HDR BT for Prostate Cancer: Feasibility and Initial Experiences Ferenc Lakosi Jos Lamers 6